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Mesenchymal stem cells (MSCs) in bone marrow (BM) regulate the differentiation and proliferation of adjacent hematopoietic precursor cells
and contribute to the regeneration of mesenchymal tissues, including bone, cartilage, fat and connective tissue. BM is an important site for the
pathogenesis of human cytomegalovirus (HCMV) where the virus establishes latency in hematopoietic progenitors and can transmit after
reactivation to neighboring cells. Here we demonstrate that BM-MSCs are permissive to productive HCMV infection, and that HCMV alters the
function of MSCs: (i) by changing the repertoire of cell surface molecules in BM-MSCs, HCMV modifies the pattern of interaction between BM-
MSCs and hematopoietic cells; (ii) HCMV infection of BM-MSCs undergoing adipogenic or osteogenic differentiation impaired the process of
differentiation. Our results suggest that by altering BM-MSC biology, HCMV may contribute to the development of various diseases.
© 2006 Elsevier Inc. All rights reserved.Keywords: HCMV; Virus–host interaction; Bone marrow; Mesenchymal stem cells; Hematopoietic stem cells; Hematopoiesis; Cell differentiation; Osteogenesis;
Adipogenesis; Cell adhesionIntroduction
Bone marrow (BM) is a complex organ comprised of
hematopoietic stem cells, their progenitors and stromal cells.
In vitro, BM stromal cells are a heterogeneous population
containing predominantly fibroblasts with small subsets of
adipocytes, osteocytes, reticulocytes and endothelial cells. The
stromal cells, which are most fibroblastoid cells are differen-
tiated from mesenchymal stem cells (MSCs) that are also
referred in some reports as marrow stromal precursor cells or
stromal stem cells (Bruder et al., 1997; Majumdar et al., 1998;
Owen and Friedenstein, 1988; Pittenger et al., 1999; Reyes et al.,
2001). MSCs contribute to the regeneration of bone, cartilage⁎ Corresponding author. Fax: +1 973 972 5594.
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doi:10.1016/j.virol.2006.09.017and other mesenchymal tissues, and are present in many tissues
but are most prevalent in BM. A homogeneous population of
MSCs can proliferate in vitro as uncommitted cells capable of
self-renewal, and can be induced to differentiate along multiple
mesenchymal cell lineages including osteoblasts, adipocytes,
chondrocytes, tendocytes, myofibroblasts, as well as endothe-
lial-like and epithelial-like cells (Bruder et al., 1997; Jaiswal
et al., 1997;Majumdar et al., 1998; Oswald et al., 2004; Pittenger
et al., 1999; Reyes et al., 2001). The significance of BM-derived
MSCs (BM-MSCs) as an important cellular and functional
component of BM was demonstrated by their ability to support
hematopoiesis and modulate differentiation of hematopoietic
primitive stem cells in long-term cultures via expression of
numerous cell adhesion molecules that are important for cell-to-
cell and cell-to-matrix interactions, homing, mobilization and
trafficking, and also by providing cytokines and growth factors
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Majumdar et al., 1998, 2003; Owen and Friedenstein, 1988;
Reyes et al., 2001).
Human cytomegalovirus (HCMV), a member of the beta-
herpesvirus family, is a widespread ubiquitous pathogen
(Mocarski, 2001). HCMV is a leading cause of congenital
birth defects, as well as the major cause of a variety of life-
threatening diseases in immunocompromised individuals such
as organ and BM transplant and AIDS patients.
HCMV naturally infects a wide variety of cell types
including fibroblasts, endothelial, epithelial, neuronal and
smooth muscle cells, monocyte/macrophages, granulocytes
and BM cells (Mocarski, 2001; Plachter et al., 1996).
Following primary exposure, HCMV establishes a lifelong
latency in the host. Although cellular reservoir(s) for latent
HCMV and its persistency in the host have not been well
characterized, latent virus has been found in hematopoietic
myeloid lineage progenitor cells (Hahn et al., 1998; Kondo
et al., 1996; Minton et al., 1994; Taylor-Wiedeman et al.,
1991). Reactivation of the latent virus in BM-derived
progenitor cells has been demonstrated in vitro, and CD34+
precursor cells were recognized as a more likely primary
reservoir for latent HCMV within BM (Goodrum et al., 2002,
2004; Zhuravskaya et al., 1997). In addition, CD34+ cells
purified from blood of healthy HCMV carriers were demon-
strated to contain latent HCMV (Reeves et al., 2005).
Therefore, current models suggest that BM hematopoietic
progenitors serve as a reservoir for HCMV and may, after
reactivation, transmit the viral genome to other cells including
peripheral blood mononuclear cells (PBMCs) and cells of the
stroma (Michelson et al., 2001; Streblow and Nelson, 2003).
Because HCMV infection can cause latency, abortive or
productive infection depending on cell type, it is important to
study HCMV infection of distinct homogeneous cell popula-
tions. However, the pathogenic role of virus infection of
various BM-derived specific cell populations remains poorly
characterized.
Experiments in long-term BM cultures have indicated that
mixed populations of BM stromal cells (BMSCs) are targets of
productive HCMV infection, and that HCMVactively replicates
in BMSCs (Apperley et al., 1989; Simmons et al., 1990;
Taichman et al., 1997). Most of the studies on HCMV infection
in BMSCs, except one with myofibroblasts (Michelson et al.,
2001), were carried out using mixed populations of phenoty-
pically and functionally heterogeneous BMSCs. The under-
standing of the cell types infected with HCMV and the
consequences of the infection of distinct types of BM cells
are of critical importance to understanding the pathobiology of
HCMV infection.
BM-MSCs are unique multifunctional cells that not only
regulate the differentiation and proliferation of hematopoietic
precursor cells but also contribute to the regeneration of various
mesenchymal tissues, including bone and fat tissue. Consider-
ing the significance of BM-MSCs, we focused our study on
BM-MSCs, their multiple functions and how these functions are
affected by HCMV infection. Here we demonstrate that BM-
MSCs are permissive to productive HCMV infection, and thatHCMV significantly alters the function of MSCs. Following
infection, the repertoire of cell surface molecules in MSCs
showed definite and differential changes that led to increased
adherence of hematopoietic cells to infected MSCs, affecting
the pattern of interaction between MSCs and hematopoietic
cells. We also demonstrate that BM-MSCs induced into either
adipogenesis or osteogenesis are permissive to HCMV infection
at different phases of differentiation, and HCMV infection of
MSCs undergoing adipogenic or osteogenic differentiation
impaired the process of differentiation by blocking the
progression of cells from the undifferentiated state to terminally
differentiated osteoblasts and adipocytes. The results demon-
strate the complexity of interaction between HCMV and BM
and raise the possibility that MSCs may play a role in the
development of HCMV-associated pathology.
Results
Susceptibility of MSCs to HCMV infection
It was demonstrated that HCMVactively replicates in mixed
BM stromal cells whereas it remains latent in BM hematopoietic
cells (Hahn et al., 1998; Simmons et al., 1990; Taichman et al.,
1997; Zhuravskaya et al., 1997). We wanted to investigate
whether HCMV can infect a homogenous population of BM-
derived MSCs. To be able to monitor productive infection of
MSCs by HCMV we used two recombinant HCMV strains
expressing Green Fluorescent Protein (GFP). HCMV genome
of laboratory AD169 and clinical TB40 HCMV strains were
cloned as BAC plasmid in E. coli by homologous recombina-
tion using a pUSF-3 marker cassette containing GFP under
control of an SV40 promoter and a chloramphenicol resistance
gene as described (Marchini et al., 2001). To test MSCs'
susceptibility for HCMV infection, the cells were infected with
TB40 BAC HCMV containing the GFP reporter gene at MOI of
1 PFU/cell. After 3 days, plaques of GFP expressing cells
appeared in the monolayer of MSCs, and at day 10 over 95% of
the cells showed GFP expression (Supplementary Fig. 1A),
indicating the virus had established a fully permissive infection
in MSCs.
To exclude the possibility that latent virus can survive in
primary BM-MSCs during preparation and expansion in vitro,
and because there was no record of HCMV testing of the BM
donor, the presence of viral DNA in MSCs was tested by PCR
amplification using primers for UL56 and β-actin (as a control)
genes. No viral sequences were detected in lysates of uninfected
MSCs, whereas the infected MSCs were highly positive for
UL56 (Supplementary Fig. 1B).
To more carefully evaluate the virus growth in MSCs, the
growth properties of laboratory AD169 and clinical TB40
HCMV strains were compared in single-step (MOI=5 PFU/
cell) and multiple-step (MOI=0.1 PFU/cell) growth curve
experiments on both MSC and HFF cells (Fig. 1). There were
no differences observed in virus replication between MSC and
HFF cells at low MOI. Both AD169 and TB40E strains showed
similar growth kinetics and peak titers. Interestingly, at high
multiplicity (5 PFU/cell), the growth rate of laboratory AD169
Fig. 2. Modulation of cell surface molecule expression in MSC and HFF cells
infected with HCMV. Analysis of the expression of cell surface molecules on
MSCs (dark shaded bars) and HFFs (light shaded bars) was performed with the
use of flow cytometry. Uninfected or HCMV-infected (3 days post infection)
cells were collected and incubated with the following conjugated monoclonal
antibodies: CD29-PE, CD44-PE, CD73-PE, CD90-PE, CD105-FITC and HLA-
ABC-PE; or with CD54 or CD58 antibodies and subsequently with FITC-
conjugated secondary antibody. Nonspecific fluorescence was determined by
incubation of the cells with isotype-matched mouse monoclonal antibodies.
Antibody-treated cells were subjected to flow cytometry. Data are expressed as
relative fluorescence intensity (RFI) as a percentage of the baseline value
(isotype control). Shown data are from one representative experiment out of
three independent experiments.
Fig. 1. Characterization of HCMV infection in MSCs. Growth kinetics of
laboratory AD169 and clinical TB40 HCMV strains were compared in MSC and
HFF cells. The cells were infected with virus at a high MOI of 5 PFU/cell
(single-step growth curves, left panel) or at a low MOI of 0.1 PFU/cell
(multistep growth curves, right pane). Cell-free and cell-associated virus was
collected at indicated times and the virus titer was determined. Shown data are
from one representative experiment out of three independent experiments.
8 S.V. Smirnov et al. / Virology 360 (2007) 6–16HCMV strain on MSCs was significantly lower than that of
clinical TB40E HCMV strain, which produced virus at levels
comparable to those on HFFs (Fig. 1). The yield of AD169
HCMVon MSCs at MOI of 5 PFU/cell was consistently 10-fold
less than that on HFFs. It appeared that at high MOI, cells
infected with AD169 HCMV quickly became abrogated and
died within 4 to 6 days post infection, whereas clinical TB40
strain was able to retain MSCs from dying for prolonged time
(8 days), therefore, yielding higher viral titers.
HCMV infection alters expression of cell surface markers in
BM-MSCs
BM-MSCs express numerous cell surface molecules impor-
tant for cell-to-cell and cell-to-matrix interactions that have been
demonstrated to play a central role in support of optimal
conditions for hematopoiesis within BM, as well as cell
migration, recognition, trafficking, growth and survival
(Gronthos et al., 2003; Majumdar et al., 2003). Therefore, it
was of interest to investigate the effect of HCMV infection on
the expression of cell surface molecules that are relevant for
MSC functions in BM. Because HFFs are one of the terminally
differentiated cell types along mesenchymal lineage, and there
is a high similarity in expression patterns of many CD markers
between mesenchymal stem cells and fibroblasts (Ishii et al.,
2005), we also extended this analysis to HFFs.
MSC and HFF cells were left uninfected or HCMV-infected
at MOI of 3–5 PFU/cell for 72 h resulting in about 95% of the
cells expressing GFP. Expression levels of cell surface CD29
(integrin-beta1), CD44 (receptor for osteopontin and hyaluronic
acid/fibronectin), CD54 (ICAM-1), CD58 (LFA-3), CD73
(ecto-5′-nucleotidase), CD90 (Thy-1), CD105 (endoglin),
CD106 (VCAM-1), MHC class I (HLA-ABC), and MHC
class II (HLA-DR) were evaluated in the GFP-positive cells by
flow cytometry (Fig. 2 and data not shown). Although overall
expression profiles of cell surface molecules in uninfected MSC
and HFF cells were generally similar, certain differences in the
expression level of CD markers were also observed. For
instance, CD44, CD73, and CD105 markers consistently
showed 2 to 3 times higher levels of expression in MSCs thanin HFFs. In contrast, the expression level of ICAM-1 (CD54)
adhesion molecule in uninfected MSCs was only weakly
detectable (1.5 times over isotype control), whereas HFFs
demonstrated moderate expression of this CD marker. In
addition, MSCs were weakly positive for VCAM-1 (CD106)
expression, whereas HFFs were negative (data not shown).
The expression pattern of CD markers was dramatically
changed upon infection (Fig. 2 and data not shown). After 72 h,
a 2- to 3-fold reduction of the expression level of CD29, CD44,
CD73, CD105 surface proteins was observed in MSCs,
comparing uninfected versus HCMV-infected cells. Even a
more profound, up to 10 times, inhibition of expression of
CD90 and MHC class I markers was seen in infected MSCs.
Nevertheless, detectable levels of expression of CD90 and
MHC class I molecules were observed 72 and up to 168 h post
9S.V. Smirnov et al. / Virology 360 (2007) 6–16infection (Fig. 2 and data not shown). Similar downregulation
of cell surface molecule expression was observed in infected
HFFs with the exception of two molecules. Interestingly, in
contrast to MSCs, the expression level of CD44 and CD73
surface proteins in HFFs showed little or no alteration in
response to HCMV infection. Both MSC and HFF cells showed
significant upregulation of ICAM-1 (CD54) and LFA-3 (CD58)
surface molecule expression upon HCMV infection.
HCMV infection affects interaction between BM-MSCs and
hematopoietic cells
In light of such profound HCMV-related modulation of cell
surface molecule expression on BM-MSCs, we next investi-
gated functional consequences of this modulation for specific
cell-to-cell interactions within BM. Awhole cell adhesion assay
between BM-MSCs and various hematopoietic transformed cell
lines was used as a model. Each of the cell lines we used
represents a different stage in hematopoiesis toward monocytes
according to a review by Harris (1996): KG1a (early pluripotent
CD34+ hematopoietic stem cells), K562 (late pluripotent
hematopoietic stem cells), HL-60 (monocyte or granulocyte
progenitor-like), U937 (promonocytic), and THP-1 (monocytic)
cells. In addition, Jurkat, Molt-4 and Raji cells, representing
mature T and B lymphoblastic cell lineages, respectively, were
included in the analysis.
Results of cell adhesion experiments between hematopoietic
cell lines and non-infected monolayers of MSCs (Fig. 3A) were
quite similar to what has been reported (Majumdar et al., 2003).
We also observed preferential binding of mature hematopoietic
cell lines and T lymphoblastic cells to MSCs. Cell lines
representing early stages of hematopoietic differentiation
adhered to MSC monolayers at significantly lower rates.
Following infection for 96 h with TB40 HCMV strain at MOI
of 3–5, MSCs showed a visible increase in adherence of all
studied hematopoietic cell lines compared to uninfected cells.
However, the most dramatic changes in binding affinity wereFig. 3. Effect of HCMV infection on interaction between MSCs and hematopoietic c
infected with TB40 HCMVat MOI of 3–5 PFU/cell for 72 h, and treated with blocki
figure were labeled with PKH26 red fluorescent dye and allowed to adhere to MSCs fo
washed out and the fluorescence of cells retained in the wells was measured. Resu
performed in quadruplicate format for each target cell line. (C) MSCs were left uninfe
either UV-inactivated HCMV virions (UV-HCMV) or HCMV-free supernatants (HCM
and 72 h post infection. Data are expressed as RFI as a percentage of the baseline va
three independent experiments.observed for the promonocytic cell line U937, early pluripotent
CD34+ stem-like cell line KG1a, and late pluripotent hemato-
poietic stem-like cell line K562 (Fig. 3A). Adherence of these
cells to HCMV-infected MSCs versus the uninfected cells
increased five, three and two times, respectively.
A significant decrease of binding of U937 and Jurkat cells
to infected MSCs occurred in the presence of blocking ICAM-
1 antibodies (Fig. 3B), demonstrating the impact of upregula-
tion of ICAM-1 expression on cell adherence. Next we
investigated whether the observed upregulation of ICAM-1
expression (Fig. 2) is a direct effect of virus infection or a
bystander effect mediated by cytokines produced by CMV-
infected cells. The level of ICAM-1 expression was moderately
upregulated after 24 h of treatment of MSCs with either intact
or UV inactivated HCMV virions (Fig. 3C). HCMV-free
supernatants only slightly modulated ICAM-1 expression.
However, at 72 h only direct HCMV infection led to strong
upregulation of the level of cell surface ICAM-1 expression on
MSC.
HCMV infects MSCs differentiating into adipogenic or
osteogenic lineage
Since MSCs are pluripotent cells capable of differentiation
along mesenchymal cell lineage, we next investigated the effect
of HCMV infection on MSC differentiation into adipocytes and
osteocytes.
For adipogenic differentiation MSCs were cultured in
differentiation medium for 28 days with three cycles of
induction/maintenance as described in Methods. Subsets of
the differentiating cells were infected at the beginning of each
induction cycle (days 0, 7, 14 and 21) with TB40 BAC-GFP
HCMV at MOI of 3–5 PFU/cell. Progression of HCMV
infection in differentiating cells was monitored by visualization
of GFP expression. HCMV titers in differentiating cell cultures
infected at various time points were also determined at day 14
post infection.ells. (A and B) Adherent MSCs were seeded in 96-well plates, left uninfected or
ng ICAM antibody (B) or left untreated (A). Suspension cell lines shown on the
r 1 h at 37 °C at a ratio of 5–10 suspension/monolayer cells. Unbound cells were
lts are expressed as the percentage of adherent cells. The adhesion assay was
cted (mock), infected with TB40 HCMVat MOI of 3–5 PFU/cell or treated with
V supernatant); and ICAM-1 expression was analyzed by flow cytometry at 24
lue (isotype control). Shown data are from one representative experiment out of
10 S.V. Smirnov et al. / Virology 360 (2007) 6–16At the end of adipogenesis (day 28) more than 90% of
uninfected MSCs differentiated into adipocytes as revealed by
observation of changes in the cell morphology and formation of
lipid vacuoles visualized with Oil-red-O staining (Figs. 4A and
B). In contrast, HFFs retained their fibroblastic shape and did
not show any changes in cell morphology under adipogenic
differentiation conditions (not shown). MSCs undergoing
differentiation into adipocytes were permissive to HCMV
infection at any stage of the induction (Figs. 4C and D). Cell
cultures infected at early stages (0 and 7 days, data not shown)
developed full cytopathic effects (CPE) at day 28, and the virus
titer obtained from cell cultures at day 14 post infection was
comparable to that on HFF cells (107 PFU/ml, data not shown).
Cell cultures infected with the virus at either day 14 or day 21 of
induction were also susceptible to HCMV infection (Figs. 4C
and D). Examination by light microscopy showed that
development of HCMV infection in these cultures was
gradually accompanied by the release of fat vacuoles from the
cells into culture medium, and by the partial change of cell
morphology from lipid vacuole containing adipocyte-like
phenotype to spindle shaped MSC-like phenotype. Moreover,
the progression of virus infection negatively correlated with the
size of accumulated fats in adipocytes. However, the virus yield
finally generated from these cultures at day 14 post infection
was still relatively high (titer range between 105 and 106 PFU/
ml; data not shown). There was no difference observed in virus
replication in HFFs under conditions of adipogenic induction
compared to regular culture conditions (data not shown).
To further evaluate the effect of HCMV infection on
adipogenesis we compared effects of active HCMV infection
with that of UV-inactivated HCMV virions and virus-free
supernatants on the differentiation potential of MSCs. As shown
in Fig. 5A, there is an evident inhibition of adipocyte formation
in the presence of virus-free supernatants and UV-inactivated
virions. No loss in cell number was observed as determined with
Giemsa staining (data not shown). However, in cultures treated
with infectious virions, the effect of inhibition of adipocyte
formation was more profound and was accompanied by loss of
cells as a result of lytic infection.
To induce osteogenesis, MSCs were cultured in osteogenic
differentiation medium for 28 days and were infected with
HCMVat either day 0, 7, 14 or 21 of induction. For comparison,
HFFs were also cultured in osteogenic medium and infected
with virus on the same schedule as MSCs. At day 28 of
differentiation MSCs showed changes in cell morphology, from
spindle shaped to cuboidal shaped, and a specific formation of
nodular aggregates and calcium mineralization (black granular
deposits) were evident (Fig. 4E). HFFs only modestly
responded to osteogenic medium by calcium deposition (Fig.
4F). Mineralization of the extracellular matrix was apparent
beginning at days 5 to 7 and was confirmed by calcium
accumulation assay (Fig. 5B). Osteogenesis-induced MSCs
were permissive for virus infection at all times tested (Figs. 4G
and H, and data not shown). In MSCs infected with HCMV at
days 0 or 7 of osteogenic induction (Fig. 4G, and data not
shown), full CPE developed by day 28. In MSCs infected with
HCMV at day 14 or 21 of osteogenic induction (Fig. 4H, anddata not shown), specific formation of nodular aggregates and
calcium mineralization were significantly impaired. To quantify
effects of HCMV infection on osteogenic differentiation,
mineral deposition in cell cultures was measured at the end of
osteogenic differentiation (day 28; Fig. 5B). While MSCs
grown in osteogenic differentiation medium without infection
showed significant calcium deposition, when HCMV was
added into differentiating cell cultures, calcium mineralization
was inhibited in a time-dependent manner (Figs. 4G and H, and
5B). It appeared that cells infected at an early stage of
differentiation demonstrated a lower rate of mineralization than
those infected at later times (Figs. 4G and H, and 5B).
Interestingly, while the cells grown in control medium failed to
deposit any detectable calcium throughout the culture period,
HCMV infection alone was able to induce definite levels of
mineralization in MSCs without osteogenic induction. Low
calcium accumulation in response to virus infection was also
observed in HFFs. Osteogenic differentiating cells infected at
day 0 of differentiation yielded 106 PFU/ml at day 14 post
infection, whereas virus titer was substantially reduced
(104 PFU/ml; day 14 post infection) in differentiating MSCs
infected at day 21 of differentiation. We also observed slight
reduction (10-fold) in virus titer in HFFs under conditions of
osteogenic induction compared to regular culture conditions
(data not shown).
Discussion
HCMV is a widespread herpes virus able to establish life-
long latency in its host. Although HCMV infection is generally
asymptomatic in healthy individuals, HCMV is associated with
the development of several pathologies, including atherosclero-
sis, and HCMV recurrence from latency is a major risk factor in
immunocompromised individuals such as bone marrow trans-
plantation patients (Boeckh et al., 2003). The bone marrow
(BM), and specifically BM hematopoietic myeloid progenitor
cells, were demonstrated to harbor the latent virus (von Laer et
al., 1995). Studies demonstrated that HCMV reactivation is a
rather frequent event not only in immunosuppressed patients but
also in healthy donors (Prosch et al., 1999). Importantly, it was
demonstrated that amount of HCMV-reactive CD8+ T cells
increases with age and can constitute up to one-quarter of the
total CD8+ T cell population in elderly individuals (Khan et al.,
2002), suggesting that the immune system is increasingly aware
of the viral presence and constantly trying to eliminate the virus
from the host. Frequent viral reactivation from BM myeloid
progenitor cells should cause infection of other BM cells
including stromal cells (Streblow and Nelson, 2003). Depend-
ing on cell type, HCMV infection can lead to productive or
abortive infection, or latency. Therefore, to better elucidate
HCMV pathogenesis it is important to study HCMV infection of
specific homogenous cell populations.
Function of the bone marrow is complex and includes
maintenance of hematopoietic and stromal progenitors.
Recently identified BM-derived MSCs support proper hemato-
poiesis through cell-to-cell contact and by providing cytokines
and other factors which affect hematopoietic progenitors
Fig. 4. HCMV infection of MSCs differentiating into adipogenic or osteogenic lineage. MSCs were incubated in either adipogenic (A–D) or osteogenic (E, G and H)
differentiation media for 28 days, left uninfected or infected with TB40 BAC-GFP HCMVat MOI of 3–5 PFU/cell at days 0, 7, 14 and 21 of differentiation. HFFs (F)
were also incubated in osteogenic differentiation media for 28 days. All cultures were analyzed at day 28 of the differentiation. Lipid vacuole accumulation in
uninfected adipogenic MSC cultures was observed by regular light microscopy (A; ×600, regular light microscopy) and was confirmed with Oil red O staining (B;
×400, regular light microscopy). GFP expression was used to monitor productive HCMV infection in adipogenic cultures infected at day 14 (C; ×600, merged regular
and fluorescent light microscopy) or day 21 of differentiation (D; ×400; merged regular and fluorescent light microscopy). MSCs (E) and HFFs (F), incubated in
osteogenic differentiation media, were photographed to observe calcium deposition in the cells (×400; regular light microscopy). GFP expression was used to monitor
productive HCMV infection in osteogenic cultures infected at day 7 (G) or day 21 of differentiation (H) (×400; merged regular and fluorescent light microscopy).
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Fig. 5. Effect of HCMVinfection on adipogenesis and osteogenesis. (A) MSCs were seeded in 12-well plates and left uninfected (mock), infected with TB40 HCMVat
MOI of 3–5 PFU/cell or treated with either UV-inactivated HCMV virions (UV-HCMV) or HCMV-free supernatants (HCMV supernatant) for 1 day at the beginning
of each cycle of induction/maintenance and then maintained in differentiation medium on the same schedule as described above in Fig. 4 legend for 2 cycles. After
14 days the adipogenic cultures were stained with Oil red O and adipocytes (cells containing lipid vacuoles) were counted. The number of adipocytes is shown as a
percentage of the total number of all cells. Data represent results of 5 countings in each out of three wells. (B) MSCs and HFFs were cultured in standard or osteogenic
differentiation media (ODM) for 28 days. Cells were left uninfected or infected with TB40 BAC-GFP HCMV at indicated days (7, 14 and 21) of osteogenic
differentiation. Calcium deposition in the cells was determined at day 28. Total calcium (μg/dish) was calculated from standard solutions. Assays were done in
triplicate at each time point.
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Kronenwett et al., 2000). In addition, during injury and as a part
of constant renewal of various tissues such as bone and
cartilage, BM-MSCs are likely to serve as a major source for
regeneration and renewal of the cells of mesenchymal lineage.
Considering the importance of MSCs, we investigated whether
HCMV can infect BM-derived purified MSCs and the mode and
the impact of the virus infection on self-renewal and
differentiation potential of the MSCs as well as on their
function in supporting hematopoiesis.
We first demonstrated that HCMV was able to establish
productive infection in a homogenous population of BM-
derived MSC cells (Figs. 1 and 1 supplement). Both
attenuated laboratory AD169 HCMV strain, which infects
only HFFs, and clinical TB40 HCMV strain replicated
equally well in MSC and HFF cells with similar growth
kinetics at MOI of 0.1 PFU/cell (Fig. 1). However, at high
MOI of 5 PFU/cell, the titer of AD169 HCMV strain on
MSCs at days 6 and 8 post infection was consistently 10-fold
less than that on HFFs. In contrast, the yield of clinical TB40
HCMV strain appeared to be similar on MSC and HFF cells
regardless of MOI (Fig. 1). We also observed that at high
MOI, cytopathic effects (CPE) induced by AD169 HCMV
strain in MSCs were apparent within 4 to 6 days, whereas
CPE produced by TB40 HCMV in MSCs appeared at day 8
post infection. HCMV developed several mechanisms to
manipulate cell cycle progression and apoptosis of the
infected cells (Mocarski, 2002). It was demonstrated that
some of these HCMV-encoded anti-apoptotic proteins are
mutated in laboratory strains and are dispensable for HCMV
replication in HFFs in vitro (Skaletskaya et al., 2001).
Therefore, our data suggest that MSCs are more sensitive to
HCMV-induced cell killing, and that some viral genes, which
are likely to be present in clinical and not in laboratory
HCMV strains, may be required to prolong the viability of
HCMV-infected cells allowing more efficient viral replication.HCMV modulates many aspects of immune response
through a variety of mechanisms including expression of
several viral immunomodulatory proteins such as cmvIL-10,
and dysregulation of expression of cellular cytokines and
surface molecules in infected cells (Kotenko et al., 2000;
Mocarski, 2002). It was shown that the expression level of
adhesion molecules in a variety of cell types is increased upon
HCMV infection and affect the adherence and activation of
leukocytes to infected cells (Knight et al., 1999; Michelson et
al., 2001; Rahbar and Soderberg-Naucler, 2005). In contrast,
cell surface markers that are involved in immune surveillance
are downregulated by HCMV (Ahn et al., 1996; Leis et al.,
2004). Because BM-MSCs express numerous cell surface
molecules which can affect cell-to-cell interactions and
modulate hematopoiesis, we next analyzed the effect of
HCMV infection on the expression pattern of several cell
adhesion molecules from integrin and immunoglobulin
families, that are important for interaction of MSCs with cells
of hematopoietic lineage (Majumdar et al., 2003). We observed
that the expression levels of ICAM-1 (CD54) and LFA-3
(CD58) were upregulated in MSCs upon HCMV infection
(Fig. 2). To test whether modulation of adhesion molecule
expression has functional implications, we then tested the
interaction between hematopoietic cell lines and HCMV-
infected MSCs. We observed increased adherence of all
hematopoietic cell lines we investigated (Fig. 3A). ICAM-1
strongly contributed to the increase in adherence of hemato-
poietic cells to HCMV-infected MSCs (Fig. 3B) and upregula-
tion of ICAM-1 expression required direct virus infection (Fig.
3C). Interestingly, while the cells of lymphoid origin (lympho-
blastic Jurkat and Molt-4 T cells, and Raji B cells) showed
higher binding affinity to uninfected MSCs then cells of the
myeloid lineage, when MSCs were infected with HCMV, cells
of myeloid origin (U937 and K562) as well as the CD34+
progenitor cell line KG1a exhibited the greatest increases in
adherence (Fig. 3A). These HCMV-mediated changes in
13S.V. Smirnov et al. / Virology 360 (2007) 6–16interaction between MSCs and hematopoietic cells may have
various biological consequences such as dysregulation of
hematopoiesis and myelosuppression which is known to occur
during HCMV infections (Randolph-Habecker et al., 2002).
Increased cell adherence can also promote the spread of HCMV
infection between various cells of BM.
In contrast to ICAM-1 and LFA-3, molecules involved in
immune recognition of infected cells such as MHC class I and II
antigens were strongly downregulated upon HCMV infection
(Fig. 2) confirming the ability of HCMV to circumvent immune
surveillance. Other CD markers such as CD29, CD44, CD73
and CD105 were also downregulated in HCMV-infected MSCs
demonstrating that HCMV exerts a profound effect on the
expression of many cellular proteins. Importance of the
modulation of the expression level of many cell surface
molecules in MSCs and other cells for HCMV pathogenesis
remains to be further investigated.
Because MSCs have the capacity to differentiate along
mesenchymal cell lineages and, therefore, contribute to the
regeneration of bone, cartilage and other mesenchymal tissues,
we also investigated the effect of HCMV infection on MSC
differentiation into adipocytes and osteocytes. For the first time
we demonstrated that cells induced into either adipogenesis or
osteogenesis are permissive to HCMV infection at every step of
differentiation progression from undifferentiated precursors to
differentiated adipocytes or osteoblasts (Fig. 4). Although even
highly differentiated cultures were permissive to HCMV
infection, the virus yield (day 14 post infection) generated
from differentiating cultures infected at day 21 of differentiation
was reduced in comparison to the viral yield harvested from
cultures infected at day 0 of differentiation, suggesting that
differentiated cells were less supportive for productive viral
replication. We also observed that HCMV infection of MSCs
undergoing adipogenic or osteogenic differentiation impaired
the process of differentiation. During adipogenesis HCMV
infection was accompanied by the gradual release of fat
vacuoles from the infected cells into culture medium, and by
the partial change of cellular morphology form adiposite-like to
MSC-like appearance (Fig. 4). During osteogenesis HCMV
infection reduced calcium deposition in cells in a time-
dependent manner: cell cultures infected at an early stage of
osteogenic differentiation demonstrated a lower rate of miner-
alization than those infected at later times (Figs. 4 and 5).
In conclusion, our experiments demonstrate that BM-derived
MSCs are permissive to productive HCMV infection, and that
HCMV can significantly alter the function of MSCs. The
following scenario can be proposed. After reactivation of
HCMV from its latency in hematopoietic progenitor cells in
BM, MSCs, residing in close vicinity, may represent the first
easily accessible target for successful replication and dissemi-
nation of the virus. Therefore, frequently occurring HCMV
reactivations may result in the depletion of uncommitted MSCs
from BM and/or may lead to the substantial loss of MSC
potential for renewal and ability to differentiate into specialized
cells and tissues. This may have severe consequences. For
example, HCMV-caused depletion and inability of MSCs to
support osteoblast regeneration may contribute to the develop-ment of osteoporosis in elderly people. Similarly, HCMV-
mediated deterioration of MSCs may result in impaired
regeneration of cartilage tissues and, therefore, contribute to
the pathogenesis of arthritis. The infection could also alter
cytokine milieu in BM. These changes may affect hematopoi-
esis and change the properties and functions of immune
progenitor cells. Therefore, frequent virus reactivations in BM
cells and subsequent productive HCMV infection of MSCs may
be an underlying cause of various pathological conditions.
Methods
Cells
MSCs at passage two were purchased from Cambrex Bio
Science (Walkersville, MD) or established from normal iliac
crest bone marrow aspirates obtained from two healthy
volunteers as described (Potian et al., 2003). Based on the
position outlined by the International Society for Cellular
Therapy on the nomenclature of MSCs, we have designated
the cells as MSCs (Horwitz et al., 2005). At passage 5, MSCs
were verified by morphology, phenotype, and differentiation
(Conget and Minguell, 1999). The cells were adherent to
plastic, morphologically symmetrical compared with the
asymmetry of fibroblasts, replicated by asymmetry, expressive
of telomerase, and able to differentiate into several cell
lineages. Based on these indicators, the MSCs used in this
study were more than 99% pure. MSCs were cultured in MSC
Growth Medium (MGM) consisting of a mixture (1:1) of
Dulbecco's modified Eagle's medium DMEM (low glucose)/
Ham's F-12 plus 10% selected FCS (HyClone, Logan, UT).
Pooled population of human foreskin fibroblasts (HFFs)
obtained from several donors were propagated in DMEM
supplemented with 10% FBS. In this study, MSCs and HFFs
were used at passages 4 to 8 and 10 to 15, respectively. All
transformed suspension cell lines except KG1a were grown in
RPMI medium with 10% FBS. KG1a cells were grown in
Iscove' DMEM with 20% FBS.
HCMV strains and virus preparation
Two strains of HCMV were used in this study: laboratory
strain AD169 (ATCC) and clinical strain TB40E (TB40) (C.
Sinzger, Tübingen, Germany), which was preferably propa-
gated on endothelial cells (ECs) and prepared from single round
infected HFF cells. Restriction digestion of HCMV TB40E and
AD169 BACs was performed and demonstrated that the pattern
of DNA fragments of TB40E BAC is different than those of
AD169 BAC (Supplementary Fig. 1C).
HCMV BAC-GFP viruses were engineered by introducing
BAC vector (Marchini et al., 2001) into the viral genome of the
wild-type AD169 and TB40 strains. In these constructs the
US1–11 region was replaced with a pUSF-3 marker cassette
containing GFP under control of an SV40 promoter and a
chloramphenicol resistance gene as described (Marchini et al.,
2001). The BAC viruses were reconstituted by electroporation
of BAC DNA into fibroblasts, together with a plasmid
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viral DNA (Baldick et al., 1997).
Infected cells and supernatants were harvested, thawed and
frozen twice, and cleared of cell debris, resulting in HCMV-
containing media. HCMV-free supernatants were generated
by ultracentrifugation of HCMV-containing media at 55 K×g
for 1 h followed by the exposure of virus-free supernatants to
254 nm UV light (40 W) for 1 h. The absence of infectious
virions was confirmed by plaque assay on HFFs. Virions
were purified by density gradient centrifugation through a D-
sorbitol cushion at 55K×g for 1 h as described (Stinski,
1976). Virions were resuspended in DMEM with 2% FBS,
and virus stocks were stored at −80 °C. Virus titers were
determined in duplicate by plaque assay on HFFs. For
inactivation, virus stocks were exposed to 254 nm UV light
(40 W) for 1 h prior to infection.
Growth curves
2×105 MSC or HFF cells/well in a 12-well plate were
infected with virus at a high multiplicity of infection (MOI) of
5 PFU/cell for single-step growth curves, or at a low MOI of
0.1 PFU/cell for multistep growth curves. At the times indicated
in Fig. 1, infected cells and supernatants were harvested and
stored at −80 °C until the end of the experiment. The samples
were thawed and frozen, cleared of cell debris, and the virus titer
was determined by plaque assay on HFFs.
FACS analysis
Analyses of cell surface molecules on MSC and HFF cells
were performed using flow cytometry. Cells recovered from
flasks by trypsin–EDTA treatment were washed in flow
cytometry buffer consisting of 2% BSA and 0.1% sodium
azide in PBS. Aliquots (1×105 cells) were incubated with the
following conjugated monoclonal antibodies: CD29-PE,
CD44-PE, CD73-PE, CD90-PE, CD105-FITC, HLA-ABC-
PE, HLA-DR-PE (PharMingen, San Diego, CA); or with
CD54 (ICAM-1)-purified, CD58 (LFA-3)-purified, and
CD106 (VCAM-1)-purified (R&D Systems, Minneapolis,
MN), followed by incubation with secondary goat anti-
mouse PE-conjugated antibodies where necessary. After
incubation, cells were washed and resuspended in flow
cytometry buffer containing 1% paraformaldehyde. Nonspe-
cific fluorescence was determined by incubation of similar
cell aliquots with isotype-matched mouse monoclonal anti-
bodies (PharMingen), or with secondary antibody alone. Data
were analyzed by collecting 10,000 events on a Becton-
Dickinson Vantage instrument. The resultant values were
normalized to the values obtained for the baseline (isotype
control). Data were expressed as relative fluorescence
intensity (RFI) as a percentage of this baseline value.
Cell adhesion assay
MSCs were seeded at 10,000 cells/well in 96-well plates.
When cells reached confluence, they were infected at MOI of3–5 PFU or left uninfected for 72 h. For experiments with
blocking antibody, MSCs were treated with 1 μg/well mouse
anti-human ICAM-1 (CD54) monoclonal antibody (R&D
Systems, Minneapolis, MN) for 1 h at 37 °C. The number of
uninfected and infected cells was counted on the day of
experiment. Transformed suspension cell lines were labeled
with the PKH26 Red Fluorescent Cell linker kit (Sigma
Diagnostics, St. Louis, MO) according to the manufacturer's
instructions. Cell viability and labeling were both 100%, as
determined by trypan blue exclusion and fluorescence micro-
scopy, respectively. Wells of MSCs were washed with PBS
three times and 100,000 labeled target cells in 100 μl PBS were
added into each well so that a ratio of 5–10 suspension/
monolayer cells was achieved. For each target cell line, the
adhesion assay was performed in quadruplicate format. After
1.5-h incubation at 37 °C, the wells were carefully washed 3
times with PBS. Fluorescence was read using Microplate
Fluorescence Reader FL500 (Bio-Tek Instruments, Winooski,
VT) at excitation of 535 nm and emission of 580 nm. To
correlate the retained fluorescence with the number of bound
cells in each well, a series of dilutions for each labeled target
cell line was prepared and average fluorescence of quadrupli-
cate wells was determined. Wells with only MSCs were used as
background values. Results were expressed as the percentage of
adherent cells.
Adipogenic and osteogenic differentiation of MSCs
To induce osteogenic or adipogenic differentiation of MSCs,
the protocols described by the manufacturer (Cambrex) were
used. MSCs at passage 4 to 8 were seeded at 4×104 cells per
well in a 24-well plate and cultured in MGM to confluence.
For induction of adipogenesis MSCs were stimulated with
three cycles of induction/maintenance. Each cycle consisted of
feeding MSCs with adipogenic differentiation medium supple-
mented with h-Insulin, dexamethasone, indomethacin, IBMX
(3-isobuty-l-methyl-xanthine) for 3–4 days followed by 1–
3 days of culturing in adipogenic maintenance medium
(Cambrex). After 3 complete cycles of induction/maintenance,
the cultures were maintained for 7 more days in adipogenic
maintenance medium with medium replacement every 2–
3 days. Adipogenic differentiation was visualized by staining
with fresh Oil-red-O solution (Sigma). For control, MSCs were
cultured in MGM followed by adipogenic maintenance medium
on the same schedule. For comparison purposes the experiment
in the same format was performed with HFF cells.
For induction of osteogenesis the growth medium was
replaced with osteogenic differentiation medium (Cambrex)
supplemented with 10 mM β-glycerophosphate, 100 nM
dexamethasone, and 50 μg/ml ascorbic acid-2-phosphate. The
induced cultures were maintained in osteogenic differentiation
medium for 3 weeks and fed twice a week by completely
replacing the medium with fresh differentiation medium.
Untreated cultures of MSCs were maintained in MGM on the
same schedule during this period of time. For comparison
purposes, the experiment in the same format was performed
with HFFs.
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At various times (days 0, 7, 14, 21) of differentiation process,
subsets of the differentiating cells (3 wells of the cells per
infection time) were infected with TB40 BAC-GFP HCMV at
MOI of 3–5 PFU/cell in MGM. After 2 h of incubating with
virus, the cells were washed once with MGM and the
differentiation medium was replaced. The cells were maintained
in differentiation medium on the same schedule as described
above. The total virus titer in differentiating cell cultures was
determined at day 14 post infection by plaque assay on HFFs.
To check if the differentiation medium may have an effect on
virus replication and for comparison purposes, the experiment
in the same format was performed with HFFs.
Calcium assay
Cell layers were rinsed twice with PBS and scraped off the
dish in 0.5 N HCl. The calcium was extracted from the cell
layers by shaking for 4 h at 4 °C, and then centrifuging at
1000×g for 5 min. The resulting supernatant was used for
quantitative calcium determination by calcium dye complex
method according to the manufacturer's instructions (Diagnos-
tic Chemicals Limited, Charlottetown, PE, Canada). Absor-
bency of samples was determined at 575 nm. Total calcium was
calculated from standard solutions prepared in parallel, and
expressed as microgram per dish. Assays were done in triplicate
at each time point.
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